Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.41 |
| ▸ | THRB | P10828 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 5/20 | 0.41 |
| ▸ | FAAH | O00519 | 4/20 | 0.41 |
| ▸ | PLA2G6 | O60733 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.37 |
| ▸ | PRKCG | P05129 | 2/20 | 0.37 |
| ▸ | PRKCB | P05771 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5382481 | 0.97 | CES2 (0.45) | CES2THRBMAPTGMNNTP53 | |
| SCHEMBL29462497 | 0.97 | CES2 (0.45) | CES2THRBMAPTGMNNTP53 | |
| SCHEMBL7602668 | 0.97 | CES2 (0.45) | CES2THRBMAPTGMNNTP53 | |
| SCHEMBL11852318 | 0.95 | THRB (0.46) | CES2THRBMAPTGMNNTP53 | |
| SCHEMBL29462498 | 0.93 | THRB (0.45) | CES2THRBMAPTGMNNTP53 | |
| SCHEMBL6694682 | 0.87 | HTT (0.54) | CES2THRBMAPTCES1MEN1 | |
| SCHEMBL9292781 | 0.87 | THRB (0.48) | CES2THRBMAPTGMNNTP53 | |
| SCHEMBL7637734 | 0.87 | HTT (0.54) | CES2THRBMAPTCES1MEN1 | |
| SCHEMBL9344102 | 0.87 | THRB (0.48) | CES2THRBMAPTGMNNTP53 | |
| SCHEMBL9344095 | 0.87 | THRB (0.48) | CES2THRBMAPTGMNNTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8076287-B2 | Cyclic hexadepsipeptides, processes for their production and their use as pharmaceuticals | THALLION PHARMACEUTICALS INC. (CA) | 2011-12-13 | — | — | US | disclosed |
| US-20110028458-A1 | INHIBITION OF CELL MIGRATION BY A FARNESYLATED DIBENZODIAZEPINONE | THALLION PHARMACEUTICALS INC. (CA) | 2011-02-03 | — | — | US | disclosed |
| WO-2010019775-A2 | METHODS OF TREATING RAS DRIVEN CANCER IN A SUBJECT | THALLION PHARMACEUTICALS INC. (CA) | 2010-02-18 | — | — | WO | disclosed |
| US-7655646-B2 | Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals | THALLION PHARMACEUTICALS, INC. (CA) | 2010-02-02 | — | — | US | disclosed |
| WO-2009124399-A1 | INHIBITION OF CELL MIGRATION BY A FARNESYLATED DIBENZODIAZEPINONE | THALLION PHARMACEUTICALS INC. (CA) | 2009-10-15 | — | — | WO | disclosed |
| US-20090215789-A1 | CYCLIC HEXADEPSIPEPTIDES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS | THALLION PHARMACEUTICALS, INC. (CA) | 2009-08-27 | — | — | US | disclosed |
| US-20090170837-A1 | METHODS FOR TREATING RAS DRIVEN CANCER IN A SUBJECT | THALLION PHARMACEUTICALS INC. (CA) | 2009-07-02 | — | — | US | disclosed |
| EP-1809612-A4 | DIBENZODIAZEPINONE ANALOGUES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS | THALLION PHARMACEUTICALS INC (CA) | 2009-05-27 | — | — | EP | disclosed |
| US-20090062255-A1 | TUMOR-TARGETING EVALUATION METHODOLOGY AND COMPOUNDS RELATED THERETO | THALLION PHARMACEUTICALS INC. (CA) | 2009-03-05 | — | — | US | disclosed |
| US-20090029972-A1 | Dibenzodiazepinone Analogues, Processes for Their Production and Their Use as Pharmaceuticals | ECOPIA BIOSCIENCES INC (CA) | 2009-01-29 | — | — | US | disclosed |
| WO-2007126849-A1 | CYCLIC HEXADEPSIPEPTIDES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS | THALLION PHARMACEUTICALS INC. (CA) | 2007-11-08 | — | — | WO | disclosed |
| EP-1809612-A1 | DIBENZODIAZEPINONE ANALOGUES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS | Ecopia Biosciences Inc. (CA) | 2007-07-25 | — | — | EP | disclosed |
| US-20060106028-A1 | Polycyclic aromatics and derivatives thereof and processes for their preparation | ECOPIA BIOSCIENCES, INC. | 2006-05-18 | — | — | US | disclosed |
| WO-2006047891-A1 | POLYCYCLIC AROMATICS AND DERIVATIVES THEREOF AND PROCESSES FOR THEIR PREPARATION | ECOPIA BIOSCIENCES INC. (CA) | 2006-05-11 | — | — | WO | disclosed |
| US-20060079512-A1 | Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals | ECOPIA BIOSCIENCES, INC. | 2006-04-13 | — | — | US | disclosed |
| US-20060079509-A1 | Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals | ECOPIA BIOSCIENCES, INC. | 2006-04-13 | — | — | US | disclosed |
| WO-2006034574-A1 | DIBENZODIAZEPINONE ANALOGUES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS | ECOPIA BIOSCIENCES INC. (US) | 2006-04-06 | — | — | WO | disclosed |
| US-20030216246-A1 | Transition metal complexes containing sulfur ligands, and polylefin production processes using them | COOK JESSICA A (US) | 2003-11-20 | — | — | US | disclosed |
| EP-1328558-A2 | TRANSITION METAL COMPLEXES CONTAINING SULFUR LIGANDS, AND POLYOLEFIN PRODUCTION PROCESSES USING THEM | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2003-07-23 | — | — | EP | disclosed |
| WO-2002032967-A2 | TRANSITION METAL COMPLEXES CONTAINING SULFUR LIGANDS, AND POLYOLEFIN PRODUCTION PROCESSES USING THEM | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2002-04-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062255-A1 | TUMOR-TARGETING EVALUATION METHODOLOGY AND COMPOUNDS RELATED THERETO | TSPO, MAPK1, MAPK3 | CES2 4117/4885THRB 846/4885MAPT 4015/4885 |
| US-20060079509-A1 | Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals | UGT2B17, CYP1B1, CYP2C19 | CES2 332/4885THRB 584/4885MAPT 2130/4885 |
| US-20060079512-A1 | Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals | UGT2B17, CYP1B1, CYP2C19 | CES2 332/4885THRB 584/4885MAPT 2130/4885 |
| US-20060106028-A1 | Polycyclic aromatics and derivatives thereof and processes for their preparation | CYP51A1, PAH, DPM1 | CES2 1545/4885THRB 3806/4885MAPT 2926/4885 |
| US-20090170837-A1 | METHODS FOR TREATING RAS DRIVEN CANCER IN A SUBJECT | KRAS, NRAS, HRAS | CES2 2724/4885THRB 1047/4885MAPT 4633/4885 |
| US-20110028458-A1 | INHIBITION OF CELL MIGRATION BY A FARNESYLATED DIBENZODIAZEPINONE | NRAS, KRAS, CDC42 | CES2 2828/4885THRB 2548/4885MAPT 4450/4885 |
| US-20090029972-A1 | Dibenzodiazepinone Analogues, Processes for Their Production and Their Use as Pharmaceuticals | UGT2B17, CYP1B1, UGT2B7 | CES2 328/4885THRB 514/4885MAPT 2118/4885 |
| US-20090215789-A1 | CYCLIC HEXADEPSIPEPTIDES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS | HM13, VIP, NPEPPS | CES2 1332/4885THRB 3731/4885MAPT 2606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.